Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Burak Eric Insider Profile
4 Followers
Burak Eric, CTO at Fusion Pharmaceuticals, holds 0.00 shares in Fusion Pharmaceuticals (Ticker: FUSN).
Burak Eric Fusion Pharmaceuticals (FUSN)CTO
Fusion Pharmaceuticals (FUSN)
CTO
Not Ranked
Burak Eric has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Burak Eric does not currently own shares as a corporate insider.
A breakdown of Burak Eric's holdings
Insider Roles
Burak Eric does not currently hold a role as a corporate insider.
Roles that Burak Eric holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Burak Eric
Burak Eric's Trading History
List of latest transactions for each holding click on a transaction to see Burak Eric's performance on stock
You May Also Like
Burak Eric insider profile FAQ
What is the percentage of profitable transactions made by Burak Eric?
The percentage of profitable transactions made by Burak Eric is ―.
What is the average return per transaction made by Burak Eric?
The average return per transaction made by Burak Eric is ―.
What stocks does Burak Eric hold?
Burak Eric holds: FUSN stocks.
What was Burak Eric’s latest transaction?
Burak Eric latest transaction was an Uninformative Sell of ―.
What was Burak Eric's most profitable transaction?
Burak Eric’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Burak Eric's role in Fusion Pharmaceuticals?
Burak Eric's role in Fusion Pharmaceuticals is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.